Frank J. Accurso, M.D.
Affiliations: | Children's Hospital Colorado, Denver, Colorado, United States |
Google:
"Frank Accurso"Parents
Sign in to add mentor| Ernest K.Cotton | fellowship/program director | 1978-1980 | Colorado General Hospital |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| LeGrys VA, Moon TC, Laux J, et al. (2018) A multicenter evaluation of sweat chloride concentration and variation in infants with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| DeBoer EM, Wagner BD, Popler J, et al. (2018) Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid. Proteomics. Clinical Applications. e1800085 |
| Hoppe JE, Wagner BD, Accurso FJ, et al. (2018) Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Mayer-Hamblett N, Retsch-Bogart G, Kloster M, et al. (2018) Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial. American Journal of Respiratory and Critical Care Medicine |
| Accurso FJ. (2018) Treatment of cystic fibrosis in infants. The Lancet. Respiratory Medicine |
| Jain R, Beckett VV, Konstan MW, et al. (2017) KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Hoppe JE, Wagner BD, Sagel SD, et al. (2017) Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis. Bmc Pulmonary Medicine. 17: 188 |
| Zemanick ET, Wagner BD, Robertson CE, et al. (2017) Airway microbiota across age and disease spectrum in cystic fibrosis. The European Respiratory Journal. 50 |
| Pittman JE, Noah H, Calloway HE, et al. (2017) Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection. Plos One. 12: e0177215 |
| DeBoer EM, Kroehl M, Wagner BD, et al. (2017) Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis. Proteomics. Clinical Applications |